Navigation Links
Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
Date:7/29/2011

islation affecting pharmaceutical pricing and reimbursement.  Government and others’ regulations and reimbursement policies may affect the development, usage and pricing of our products.  Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.  We, or others, could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and product liability claims.  Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product.  Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers.  

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medi
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
3. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... GAITHERSBURG, Md. , Aug. 5, 2015 /PRNewswire/ ... an oncology company focusing on genetic and epigenetic ... research and development arm of AstraZeneca, today announced ... collaboration ("Collaboration Agreement"). The Phase I/II study will ... spectrum-selective histone deacetylase (HDAC) inhibitor, mocetinostat, in combination ...
(Date:8/5/2015)... Mordor Intelligence releases their report ... segmented by Packaging Type for Ampoules (Glass, Plastic) - ... Geographical Region ( North America , ... & Africa ) - ... Analysis (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799 ) ...
(Date:8/4/2015)... , Aug. 4, 2015 Young ... supplies and equipment, today announced the acquisition of ... Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD manufactures ... in preventive and restorative dental procedures. ... of our business in attractive, high-growth segments," said ...
Breaking Medicine Technology:Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 2Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 3Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 4Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 5Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer 6DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... REDWOOD CITY, Calif., Feb. 11, 2011 – AcelRx Pharmaceuticals, ... company focused on the development and commercialization of innovative ... today announced the pricing of its initial public offering ... per share. All of the common stock will be ...
... Renaissance Surgical Arts at Newport Harbor announced today that ... United States to offer intraoperative radiotherapy (IORT) using the INTRABEAM® ... human clinical trial that demonstrated IORT to be as effective ... IORT has the potential to replace as ...
Cached Medicine Technology:AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 3
(Date:8/5/2015)... ... August 05, 2015 , ... Hotze ... industry, is pleased to announce that it has added Electronic Beam Computed Tomography ... The scanner will be used primarily for conducting coronary artery scans and ...
(Date:8/5/2015)... ... ... the makers of the nation’s leading line of recovery drinks, has answered consumers’ calls once ... brew is smooth, rich and ready to travel, in three flavors. It tastes awesome because ... need milk and sugar to taste great like other traditional ready to drink coffees. ...
(Date:8/5/2015)... ... August 05, 2015 , ... Optimized Care Network (OCN) will join providers ... provide more patient choice during the first-ever Convenient Healthcare and Pharmacy Collaborative, Aug. 6-7. ... the challenges confronting retail clinics, how to expand their role and future trends in ...
(Date:8/5/2015)... ... 05, 2015 , ... i2i Systems announces the appointment of ... Systems team during a period of growth and platform expansion, driven by the ... to new shared-risk models that support enhanced clinical and financial outcomes and profitable ...
(Date:8/5/2015)... ... 05, 2015 , ... "Art de Toilettes" , It all ... suggest ideas to add some fun and visual interest to the company lobby. ... transform toilets into works of art. Renew Life makes natural digestive care supplements ...
Breaking Medicine News(10 mins):Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 2Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 3Health News:Kill Cliff® Releases Epic New Product Line – Coffeehouse Quality Cold Brew Coffee in a Can 2Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 2Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 3Health News:i2i Systems Hires Healthcare Industry Authority Justin L. Neece as Chief Operations Officer 2Health News:Fantastic Team Spirit and Creativity Prevailed at Renew Life “Art de Toilettes” 2
... ... ... , , ... WASHINGTON , Feb. 25 ...
... ... ... ... ...
... ... ... , , , ... ...
... , , ... ... ... ...
... policymakers make reasonable decisions when they have limited ... Charles F. Manski explores in his new paper, ... paper is published online by the Proceedings ... at http://www.pnas.org/content/early/2010/02/05/0915009107.full.pdf+html . "Let,s say you,re ...
... by Johns Hopkins say they have identified the mechanisms rooted ... of schizophrenia and the reason symptoms don,t develop until young ... gene known as DISC1, whose mutant form was first identified ... and related mental disorders. The findings could lead to new ...
Cached Medicine News:Health News:NORD Calls FDA Action 'An Important Advance for Patients' 2Health News:NORD Calls FDA Action 'An Important Advance for Patients' 3Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 2Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 3Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 4Health News:NSBA Implores Congress to Act on Health Care Reform 2Health News:NSBA Implores Congress to Act on Health Care Reform 3Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 2Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 3Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 4Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 5Health News:How can policymakers cope with ambiguity? 2Health News:Why symptoms of schizophrenia emerge in young adulthood 2Health News:Why symptoms of schizophrenia emerge in young adulthood 3
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: